Primary Site >> Liver Cancer

Gene >> KLF4

Journal: Cell Transplant. 2011;20(1):15-9.
Title: Induced pluripotent stem (iPS) cell research overview.
Author: Liu, Shih-Ping|Fu, Ru-Huei|Huang, Yu-Chuen|Chen, Shih-Yin|Chien, Ying-Jiun|Hsu, Chien Yu|Tsai, Chang-Hai|Shyu, Woei-Cherng|Lin, Shinn-Zong
PMID: 20887681
Journal: Oncol Rep. 2012 Jun;27(6):1865-72.
Title: Tumorigenicity of cancer stem-like cells derived from hepatocarcinoma is regulated by microRNA-145.
Author: Jia, Yongsheng|Liu, Honglin|Zhuang, Qianshu|Xu, Shiqing|Yang, Zhihua|Li, Jianzhong|Lou, Jinning|Zhang, Wenjian
PMID: 22378186
Journal: Gastroenterology. 2012 Sep;143(3):799-810.e2.
Title: Dysregulated Kruppel-like factor 4 and vitamin D receptor signaling contribute to progression of hepatocellular carcinoma.
Author: Li, Qi|Gao, Yong|Jia, Zhiliang|Mishra, Lopa|Guo, Kun|Li, Zhiwei|Le, Xiangdong|Wei, Daoyan|Huang, Suyun|Xie, Keping
PMID: 22677193
Journal: PLoS One. 2012;7(8):e43593.
Title: Kruppel-like factor 4, a tumor suppressor in hepatocellular carcinoma cells reverts epithelial mesenchymal transition by suppressing slug expression.
Author: Lin, Ze-Shiang|Chu, Hsiao-Chien|Yen, Yi-Chen|Lewis, Brian C|Chen, Ya-Wen
PMID: 22937066
Journal: Cell Cycle. 2013 Jan 15;12(2):353-64.
Title: The involvement of a Nanog, Klf4 and c-Myc transcriptional circuitry in the intertwining between neoplastic progression and reprogramming.
Author: Marzi, Ilaria|Cipolleschi, Maria Grazia|D'Amico, Massimo|Stivarou, Theodora|Rovida, Elisabetta|Vinci, Maria Cristina|Pandolfi, Silvia|Dello Sbarba, Persio|Stecca, Barbara|Olivotto, Massimo
PMID: 23287475
Journal: Oncol Lett. 2013 Apr;5(4):1155-1162.
Title: The clinical and prognostic implications of pluripotent stem cell gene expression in hepatocellular carcinoma.
Author: Yin, Xin|Li, Yi-Wei|Jin, Jian-Jun|Zhou, Yin|Ren, Zheng-Gang|Qiu, Shuang-Jian|Zhang, Bo-Heng
PMID: 23599755
Journal: PLoS One. 2013 Sep 4;8(9):e72435.
Title: Epigenetic regulation of pluripotent genes mediates stem cell features in human hepatocellular carcinoma and cancer cell lines.
Author: Wang, Xiao Qi|Ng, Ray Kit|Ming, Xiaoyan|Zhang, Wu|Chen, Lin|Chu, Andrew C Y|Pang, Roberta|Lo, Chung Mau|Tsao, Sai Wah|Liu, Xuqing|Poon, Ronnie T P|Fan, Sheung Tat
PMID: 24023739
Journal: World J Gastroenterol. 2013 Dec 21;19(47):8850-60.
Title: Cellular reprogramming and hepatocellular carcinoma development.
Author: Zheng, Yun-Wen|Nie, Yun-Zhong|Taniguchi, Hideki
PMID: 24379607
Journal: Tumour Biol. 2015 Feb;36(2):533-41.
Title: Kruppel-like factors in hepatocellular carcinoma.
Author: Lu, Xiao-Jie|Shi, Yan|Chen, Jin-Lian|Ma, Shijie
PMID: 25652467
Journal: Int J Oncol. 2015 Oct;47(4):1554-62.
Title: Identification of a non-coding KLF4 transcript generated from intron retention and downregulated in human hepatocellular carcinoma.
Author: Zhou, Junwei|Lai, Paul Bo-San|Tsui, Stephen Kwok-Wing
PMID: 26238073
Journal: Oncotarget. 2015 Nov 10;6(35):37200-15.
Title: Plasma DCLK1 is a marker of hepatocellular carcinoma (HCC): Targeting DCLK1 prevents HCC tumor xenograft growth via a microRNA-dependent mechanism.
Author: Sureban, Sripathi M|Madhoun, Mohammad F|May, Randal|Qu, Dongfeng|Ali, Naushad|Fazili, Javid|Weygant, Nathaniel|Chandrakesan, Parthasarathy|Ding, Kai|Lightfoot, Stanley A|Houchen, Courtney W
PMID: 26468984
Journal: Oncotarget. 2015 Dec 29;6(42):44452-65.
Title: Knock out CD44 in reprogrammed liver cancer cell C3A increases CSCs stemness and promotes differentiation.
Author: Han, Shuo|Guo, Jinhai|Liu, Yinan|Zhang, Zhi|He, Qihua|Li, Peng|Zhang, Mingzhi|Sun, Haojie|Li, Ruizhi|Li, Yang|Zeng, Wotan|Liu, Jinwen|Lian, Lejian|Gao, Yi|Shen, Li
PMID: 26540347
Journal: Oncol Rep. 2016 Mar;35(3):1657-63.
Title: TALEN-induced disruption of Nanog expression results in reduced proliferation, invasiveness and migration, increased chemosensitivity and reversal of EMT in HepG2 cells.
Author: Yu, Ai Qing|Ding, Yan|Li, Cheng Lin|Yang, Yi|Yan, Shi Rong|Li, Dong Sheng
PMID: 26676719
Journal: Sci Rep. 2016 Oct 11;6:34856.
Title: Hepatocellular Carcinoma-propagating Cells are Detectable by Side Population Analysis and Possess an Expression Profile Reflective of a Primitive Origin.
Author: Xia, Honghai|Cao, Jun|Li, Qing|Lv, Yang|Jia, Weidong|Ren, Weihua|Cheng, Qingyu|Song, Xiaoyuan|Xu, Geliang
PMID: 27725724
Journal: Oncotarget. 2016 Nov 1;7(44):71309-71329.
Title: Restoring miR122 in human stem-like hepatocarcinoma cells, prompts tumor dormancy through Smad-independent TGF-beta pathway.
Author: Boix, Loreto|Lopez-Oliva, Juan Manuel|Rhodes, Ana Carolina|Bruix, Jordi
PMID: 27612430
Journal: Tumour Biol. 2016 Oct;37(10):14103-14115.
Title: Arsenite inhibits the function of CD133(+) CD13(+) liver cancer stem cells by reducing PML and Oct4 protein expression.
Author: Tang, Huaming|Jin, Yukai|Jin, Shilong|Tan, Zhiming|Peng, Zhang|Kuang, Yuanli
PMID: 27517564
Journal: Am J Physiol Gastrointest Liver Physiol. 2016 Jul 1;311(1):G91-G104.
Title: Bile acids promote diethylnitrosamine-induced hepatocellular carcinoma via increased inflammatory signaling.
Author: Sun, Lina|Beggs, Kevin|Borude, Prachi|Edwards, Genea|Bhushan, Bharat|Walesky, Chad|Roy, Nairita|Manley, Michael W Jr|Gunewardena, Sumedha|O'Neil, Maura|Li, Hua|Apte, Udayan
PMID: 27151938
Journal: J Transl Med. 2016 Feb 12;14:49.
Title: Detection of ALDH1 activity in rabbit hepatic VX2 tumors and isolation of ALDH1 positive cancer stem cells.
Author: Gehlot, Prashasnika|Shukla, Vivek|Gupta, Sanjay|Makidon, Paul E
PMID: 26873175
Journal: Gut Liver. 2017 Mar 15;11(2):261-269.
Title: Establishment of Hepatocellular Cancer Induced Pluripotent Stem Cells Using a Reprogramming Technique.
Author: Kim, Han Joon|Jeong, Jaemin|Park, Sunhoo|Jin, Young-Woo|Lee, Seung-Sook|Lee, Seung Bum|Choi, Dongho
PMID: 27728962
Journal: Stud Health Technol Inform. 2017;245:667-671.
Title: Identifying Biomarkers of Hepatocellular Carcinoma Based on Gene Co-Expression Network from High-Throughput Data.
Author: Zhang, Ying|Liu, Zhiping|Li, Jing-Song
PMID: 29295180
Journal: BMC Cancer. 2017 Dec 18;17(1):862.
Title: Gene expression, regulation of DEN and HBx induced HCC mice models and comparisons of tumor, para-tumor and normal tissues.
Author: Tang, Qin|Wang, Qi|Zhang, Qiong|Lin, Sheng-Yan|Zhu, Yanhong|Yang, Xiangliang|Guo, An-Yuan
PMID: 29254483
Journal: Artif Cells Nanomed Biotechnol. 2017 Dec 18:1-9.
Title: miR-124 inhibits progression of hepatocarcinoma by targeting KLF4 and promises a novel diagnostic marker.
Author: Wu, Li-Pei|Wu, Jian|Shang, Anquan|Yang, Man|Li, Ling-Ling|Yu, Jing|Xu, Lei-Rong|Wang, Chun-Bing|Wang, Wei-Wei|Zhu, Jian-Jun|Lu, Wen-Ying
PMID: 29252002
Journal: World J Stem Cells. 2017 Sep 26;9(9):159-168.
Title: Murine hepatocellular carcinoma derived stem cells reveal epithelial-to-mesenchymal plasticity.
Author: Jayachandran, Aparna|Shrestha, Ritu|Dhungel, Bijay|Huang, I-Tao|Vasconcelos, Marianna Yumi Kawashima|Morrison, Brian J|Ramlogan-Steel, Charmaine A|Steel, Jason C
PMID: 29026462
Journal: Oncotarget. 2017 Jul 17;8(40):68263-68269.
Title: MicroRNA-18a promotes proliferation and metastasis in hepatocellular carcinoma via targeting KLF4.
Author: Liu, Li|Cai, Xun|Liu, Enqiang|Tian, Xia|Tian, Chuan
PMID: 28978114
Journal: Cancer Lett. 2017 Aug 1;400:149-160.
Title: Hepatitis B virus PreS1 facilitates hepatocellular carcinoma development by promoting appearance and self-renewal of liver cancer stem cells.
Author: Liu, Zhixin|Dai, Xuechen|Wang, Tianci|Zhang, Chengcheng|Zhang, Wenjun|Zhang, Wei|Zhang, Qi|Wu, Kailang|Liu, Fang|Liu, Yingle|Wu, Jianguo
PMID: 28455240
Journal: J Biol Chem. 2017 Feb 10;292(6):2143-2158.
Title: RYBP Expression Is Regulated by KLF4 and Sp1 and Is Related to Hepatocellular Carcinoma Prognosis.
Author: Zhao, Qiaojiajie|Cai, Weihua|Zhang, Xuan|Tian, Shuo|Zhang, Junwen|Li, Haibo|Hou, Congcong|Ma, Xiaoli|Chen, Hong|Huang, Bingren|Chen, Deng
PMID: 28028181
Journal: Int J Cancer. 2017 Mar 15;140(6):1346-1355.
Title: HBx drives alpha fetoprotein expression to promote initiation of liver cancer stem cells through activating PI3K/AKT signal pathway.
Author: Zhu, Mingyue|Li, Wei|Lu, Yan|Dong, Xu|Lin, Bo|Chen, Yi|Zhang, Xueer|Guo, Junli|Li, Mengsen
PMID: 27925189
Journal: Int J Mol Med. 2017 Jan;39(1):47-56.
Title: Klf4 inhibits tumor growth and metastasis by targeting microRNA-31 in human hepatocellular carcinoma.
Author: Tian, Chuan|Yao, Shanshan|Liu, Li|Ding, Youcheng|Ye, Qingwang|Dong, Xiao|Gao, Yong|Yang, Ning|Li, Qi
PMID: 27909734
Journal: Oncotarget. 2017 Jan 24;8(4):6067-6078.
Title: MBD3 inhibits formation of liver cancer stem cells.
Author: Li, Ruizhi|He, Qihua|Han, Shuo|Zhang, Mingzhi|Liu, Jinwen|Su, Ming|Wei, Shiruo|Wang, Xuan|Shen, Li
PMID: 27894081
Journal: Hepatology. 2018 Apr;67(4):1360-1377.
Title: Barrier to autointegration factor 1, procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3, and splicing factor 3b subunit 4 as early-stage cancer decision markers and drivers of hepatocellular carcinoma.
Author: Shen, Qingyu|Eun, Jung Woo|Lee, Kyungbun|Kim, Hyung Seok|Yang, Hee Doo|Kim, Sang Yean|Lee, Eun Kyung|Kim, Taemook|Kang, Keunsoo|Kim, Seongchan|Min, Dal-Hee|Oh, Soon-Nam|Lee, Young-Joon|Moon, Hyuk|Ro, Simon Weonsang|Park, Won Sang|Lee, Jung Young|Nam, Suk
PMID: 29059470
Journal: Cancer Cell Int. 2018 Jan 17;18:10.
Title: MicroRNA-10b regulates epithelial-mesenchymal transition by modulating KLF4/KLF11/Smads in hepatocellular carcinoma.
Author: Hujie, Gulibaha|Zhou, Sheng-Hua|Zhang, Hua|Qu, Jie|Xiong, Xiao-Wei|Hujie, Outikuer|Liao, Cheng-Gong|Yang, Shun-E
PMID: 29375271
Journal: BMB Rep. 2018 Feb;51(2):57-58.
Title: SF3B4 as an early-stage diagnostic marker and driver of hepatocellular carcinoma.
Author: Shen, Qingyu|Nam, Suk Woo
PMID: 29397868
Journal: Exp Mol Pathol. 2018 Apr;104(2):125-129.
Title: Expression of proteins upregulated in hepatocellular carcinoma in patients with alcoholic hepatitis (AH) compared to non-alcoholic steatohepatitis (NASH): An immunohistochemical analysis of candidate proteins.
Author: Lu, Jiajie George|Nguyen, Luan|Samadzadeh, Sara|Masouminia, Maryam|Mendoza, Alejandro|Sweeney, Owen|Tillman, Brittany|Afifyan, Nikoo|Morgan, Timothy|French, Barbara A|French, Samuel W
PMID: 29425759
Journal: Oncotarget. 2017 Nov 20;9(15):12471-12478.
Title: Research progress on the forkhead box C1.
Author: Wang, Jinhua|Li, Wan|Zheng, Xiangjin|Pang, Xiaocong|Du, Guanhua
PMID: 29552326
Journal: Eur J Pharmacol. 2018 Aug 5;832:39-49.
Title: Combined treatment with sorafenib and silibinin synergistically targets both HCC cells and cancer stem cells by enhanced inhibition of the phosphorylation of STAT3/ERK/AKT.
Author: Mao, Jie|Yang, Hongbao|Cui, Tingting|Pan, Pan|Kabir, Nadia|Chen, Duo|Ma, Jinyan|Chen, Xingyi|Chen, Yijun|Yang, Yong
PMID: 29782854
Journal: Oncol Rep. 2018 Sep;40(3):1657-1665.
Title: Homeobox containing 1 inhibits liver cancer progression by promoting autophagy as well as inhibiting stemness and immune escape.
Author: Zhao, Hengli|Jia, Huifeng|Han, Qiuju|Zhang, Jian
PMID: 30015890
Journal: Am J Cancer Res. 2018 Jun 1;8(6):1019-1029. eCollection 2018.
Title: KLF4 suppresses the migration of hepatocellular carcinoma by transcriptionally upregulating monoglyceride lipase.
Author: Yang, Xuejun|Zhang, Dongmei|Liu, Sha|Li, Xiaojie|Hu, Wanglai|Han, Chuanchun
PMID: 30034939